AMGEN INC

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (805)447-1000
 
CIK: 0000318154
EIN: 953540776
State Location: CA
State of Inc.: DE
 
Tickers:
  • Nasdaq:AMGN

Form: 10-K

Filing Date: 13 Feb 2026
Report Date: 31 Dec 2025
Accepted: 13 Feb 2026 02:07 p.m.
Accession Number: 0000318154-26-000010
 
Act: 34
File Number: 001-37702
Film Number: 26632737

Documents

Primary Document: 10-K
Accepted: 13 Feb 2026 02:07 p.m.
0000318154-26-000010-index-headers.html
Last Modified: 13 Feb 2026 02:07 p.m.
0000318154-26-000010-index.html
Last Modified: 13 Feb 2026 02:07 p.m.
0000318154-26-000010.txt
Last Modified: 13 Feb 2026 02:07 p.m.
0000318154-26-000010-xbrl.zip
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231.xsd
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_cal.xml
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_def.xml
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_g1.jpg
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_g2.jpg
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_htm.xml
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_lab.xml
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-20251231_pre.xml
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-ex21_2025x10xk.htm
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-ex31_20251231x10xk.htm
Last Modified: 13 Feb 2026 02:07 p.m.
amgn-ex32_20251231x10xk.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit10195-letteragreeme.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit10196-thirdamendmen.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit10197-fourthamendme.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit102-formofgrantofst.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit103-formofrestricte.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit105-formofperforman.htm
Last Modified: 13 Feb 2026 02:07 p.m.
exhibit432-descriptionofam.htm
Last Modified: 13 Feb 2026 02:07 p.m.
FilingSummary.xml
Last Modified: 13 Feb 2026 02:07 p.m.
image_0.jpg
Last Modified: 13 Feb 2026 02:07 p.m.